2026. Probable Reversible Encephalopathy with Ceftazidime/Avibactam and Aztreonam: A Case Report. Asian Journal of Pharmaceutical and Health Sciences. 16, 2 (Jun. 2026), 3283–3287. DOI:https://doi.org/10.5530/ajphs.2026.16.94.